Literature DB >> 2838456

Construction of a dihydrofolate reductase-deficient mutant of Escherichia coli by gene replacement.

E E Howell1, P G Foster, L M Foster.   

Abstract

The dihydrofolate reductase (fol) gene in Escherichia coli has been deleted and replaced by a selectable marker. Verification of the delta fol::kan strain has been accomplished using genetic and biochemical criteria, including Southern analysis of the chromosomal DNA. The delta fol::kan mutation is stable in E. coli K549 [thyA polA12 (Ts)] and can be successfully transduced to other E. coli strains providing they have mutations in their thymidylate synthetase (thyA) genes. A preliminary investigation of the relationship between fol and thyA gene expression suggests that a Fol- cell (i.e., a dihydrofolate reductase deficiency phenotype) is not viable unless thymidylate synthetase activity is concurrently eliminated. This observation indicates that either the nonproductive accumulation of dihydrofolate or the depletion of tetrahydrofolate cofactor pools is lethal in a Fol- ThyA+ strain. Strains containing the thyA delta fol::kan lesions require the presence of Fol end products for growth, and these lesions typically increase the doubling time of the strain by a factor of 2.5 in rich medium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838456      PMCID: PMC211246          DOI: 10.1128/jb.170.7.3040-3045.1988

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  31 in total

1.  Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups.

Authors:  K H Pattishall; J Acar; J J Burchall; F W Goldstein; R J Harvey
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

2.  IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI.

Authors:  K A STACEY; E SIMSON
Journal:  J Bacteriol       Date:  1965-08       Impact factor: 3.490

3.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

4.  Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.

Authors:  R G Moran; M Mulkins; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

5.  Altered dihydrofolate reductase in fol regulatroy mutants of Escherichia coli K12.

Authors:  R Sheldon
Journal:  Mol Gen Genet       Date:  1977-03-07

6.  Conditional lethality of recA and recB derivatives of a strain of Escherichia coli K-12 with a temperature-sensitive deoxyribonucleic acid polymerase I.

Authors:  M Monk; J Kinross
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

7.  Initiation of protein synthesis without formylation in a mutant of Escherichia coli that grows in the absence of tetrahydrofolate.

Authors:  B R Baumstark; L L Spremulli; U L RajBhandary; G M Brown
Journal:  J Bacteriol       Date:  1977-01       Impact factor: 3.490

8.  Regulatory mutants of dihydrofolate reductase in Escherichia coli K12.

Authors:  R Sheldon; S Brenner
Journal:  Mol Gen Genet       Date:  1976-08-10

9.  Growth and initiation of protein synthesis in Escherichia coli in the presence of trimethoprim.

Authors:  R J Harvey
Journal:  J Bacteriol       Date:  1973-04       Impact factor: 3.490

10.  Regulation of dihydrofolate reductase synthesis in Escherichia coli.

Authors:  D R Smith; J M Calvo
Journal:  Mol Gen Genet       Date:  1979-08
View more
  24 in total

1.  FolM, a new chromosomally encoded dihydrofolate reductase in Escherichia coli.

Authors:  Moshe Giladi; Neta Altman-Price; Itay Levin; Liat Levy; Moshe Mevarech
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

Review 2.  Target assessment for antiparasitic drug discovery.

Authors:  Julie A Frearson; Paul G Wyatt; Ian H Gilbert; Alan H Fairlamb
Journal:  Trends Parasitol       Date:  2007-10-24

3.  Characterization of dihydrofolate reductase genes from trimethoprim-susceptible and trimethoprim-resistant strains of Enterococcus faecalis.

Authors:  T M Coque; K V Singh; G M Weinstock; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Construction of a fol mutant strain of Escherichia coli for use in dihydrofolate reductase mutagenesis experiments.

Authors:  P M Ahrweiler; C Frieden
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

5.  A Two-Enzyme Adaptive Unit within Bacterial Folate Metabolism.

Authors:  Andrew F Schober; Andrew D Mathis; Christine Ingle; Junyoung O Park; Li Chen; Joshua D Rabinowitz; Ivan Junier; Olivier Rivoire; Kimberly A Reynolds
Journal:  Cell Rep       Date:  2019-06-11       Impact factor: 9.423

6.  Emergence of the trimethoprim resistance gene dfrD in Listeria monocytogenes BM4293.

Authors:  E Charpentier; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

7.  Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.

Authors:  R G Donald; D S Roos
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  In Vivo Titration of Folate Pathway Enzymes.

Authors:  Deepika Nambiar; Timkhite-Kulu Berhane; Robert Shew; Bryan Schwarz; Michael R Duff; Elizabeth E Howell
Journal:  Appl Environ Microbiol       Date:  2018-09-17       Impact factor: 4.792

9.  Replacement of the folC gene, encoding folylpolyglutamate synthetase-dihydrofolate synthetase in Escherichia coli, with genes mutagenized in vitro.

Authors:  C Pyne; A L Bognar
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

10.  Nonsense suppression in thymine-requiring strains of Escherichia coli is a consequence of altered folate metabolism.

Authors:  J Basso; E Tiganos; M B Herrington
Journal:  Mol Gen Genet       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.